Hout Mohammad, Sobel David, Pareek Gyan, Elsamra Sammy
Division of Urology, Department of Surgery, Brown University Alpert School of Medicine, Providence, Rhode Island, USA.
J Endourol Case Rep. 2020 Dec 29;6(4):454-456. doi: 10.1089/cren.2020.0187. eCollection 2020.
SpaceOAR (organ at risk) hydrogel is a hydrogel matrix injected into the perirectal space posterior to the prostate for the purpose of mitigating radiation dose (and hence side effects of radiation) on the rectum. Manufacturer descriptions state that this material is reabsorbed 3 to 6 months after injection. We encountered a 75-year old male patient who underwent SpaceOAR injection in anticipation for primary external beam radiation treatment for intermediate risk prostate cancer (Gleason score 7 = 4 + 3, prostate specific Antigen [PSA] = 2.32, cT2a). After initiation of androgen deprivation, but before radiotherapy, the patient decided to no longer undergo radiation but rather elected to proceed with surgery. Based on the presence of the SpaceOAR, we delayed his surgery to 6 months after SpaceOAR injection to allow for absorption of the material. A preoperative MRI showed persistent hydrogel matrix in the perirectal space. We performed a robotic radical prostatectomy effectively despite the persistent SpaceOAR hydrogel by modifying our dissection closer to the prostate posteriorly. SpaceOAR hydrogel may alter patient anatomy even 6 months after deployment, however, robotic prostatectomy would be feasible with proper knowledge of anatomy and by following the proper dissection planes above the perirectal space.
SpaceOAR(危及器官)水凝胶是一种注入前列腺后方直肠周围间隙的水凝胶基质,目的是减轻对直肠的辐射剂量(以及由此产生的辐射副作用)。制造商说明指出,这种材料在注射后3至6个月会被重新吸收。我们遇到一名75岁男性患者,他因中度风险前列腺癌( Gleason评分7 = 4 + 3,前列腺特异性抗原[PSA] = 2.32,cT2a)预期接受原发性外照射放疗而进行了SpaceOAR注射。在开始雄激素剥夺治疗后,但在放疗前,患者决定不再接受放疗,而是选择进行手术。基于SpaceOAR的存在,我们将他的手术推迟到SpaceOAR注射后6个月,以便材料吸收。术前MRI显示直肠周围间隙存在持续的水凝胶基质。尽管SpaceOAR水凝胶持续存在,我们通过在后方更靠近前列腺处进行解剖,有效地实施了机器人根治性前列腺切除术。然而,即使在SpaceOAR植入6个月后,它也可能改变患者的解剖结构,不过,在了解解剖结构并遵循直肠周围间隙上方的正确解剖平面的情况下,机器人前列腺切除术是可行的。